SCHEMBL13033712

SCHEMBL13033712

NC(=O)N[C@H]1CCS[C@H]1CCCCC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ LMNA P02545 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TARDBP Q13148 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ APEX1 P27695 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ SAE1 Q9UBE0 1/20 0.42
▸ UBA2 Q9UBT2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14215592 0.91 KMT2A (0.44) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL7687386 0.73 LMNA (0.65) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL24895977 0.73 TDP1 (0.34) TDP1
SCHEMBL20123217 0.68 KDM5A (0.45) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL5569598 0.68 TDP1 (0.42) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL11713705 0.66 LMNA (0.59) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL18309823 0.66 LMNA (0.59) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL24003308 0.66 LMNA (0.59) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL12841281 0.65 TDP1 (0.48) TDP1KMT2ALMNAALDH1A1HSD17B10
SCHEMBL9432732 0.65 TDP1 (0.48) TDP1KMT2ALMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 — — US disclosed
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CHLSN, PTMS, SRMS TDP1 2851/4885KMT2A 4241/4885LMNA 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback